Mortality and Risk Factors of Death in Patients with AmpC β -Lactamase Producing Enterobacterales Bloodstream Infection: A Cohort Study .
Ana Sheila Duarte Nunes SilvaNatália Chilinque Zambão da SilvaFernanda Moreth do ValleJaqueline Abel da RochaShelley EhrlichIanick Souto MartinsPublished in: Infection and drug resistance (2024)
BSI-ESCPM is severe and has serious outcomes such as sepsis-associated deaths. Combined antibiotic therapy was a protective factor against death in patients with BSI-ESCPM. There is a suggestive association between inadequate antibiotic therapy and mortality. The ESCPM group bacteria that are considered to be at moderate to high risk of clinically significant AmpC production were not associated with death.